Intrinsiqs

Is Novartis AG overvalued?

Novartis AG (NVS) looks fairly valued — trading about 9% below its fair value.

Fairly valued
Current price $141.00 Fair value $153.54
Price
$141.00
Fair value
$153.54
Current P/E
16.2
Normal P/E
17.7
Market cap
$268.00B
Dividend yield
3.3%
Return on equity
29.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares NVS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 3 Oct 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AG